طراحی و شبیه‌سازی نانو لینکرهای پلی‌کاتیونی برای اتصال پلی‌آنیون‌ها به یکدیگر

[1] L. S. Jones, B. Yazzie, and C. R. Middaugh, “Polyanions and the Proteome,” Mol. Cell. Proteomics, vol. 3, no. 8, pp. 746–769, 2004, doi: 10.1074/mcp.r400008-mcp200.
[2] R. Srinivas, S. Samanta, and A. Chaudhuri, “Cationic amphiphiles: promising carriers of genetic materials in gene therapy,” Chem. Soc. Rev., vol. 38, no. 12, p. 3326, 2009, doi: 10.1039/b813869a.
[3] S. M. Bromfield, E. Wilde, and D. K. Smith, “Heparin sensing and binding – taking supramolecular chemistry towards clinical applications,” Chem. Soc. Rev., vol. 42, no. 23, p. 9184, 2013, doi: 10.1039/c3cs60278h.
[4] T. Sörensen, S. Leeb, J. Danielsson, and M. Oliveberg, “Polyanions Cause Protein Destabilization Similar to That in Live Cells,” Biochemistry, vol. 60, no. 10, pp. 735–746, 2021, doi: 10.1021/acs.biochem.0c00889.
[5] “Chapter 4 Negatively Charged Polymers (Polyanions),” in Developments in Soil Science, vol. 9, pp. 95–108, 1979, doi: 10.1016/s0166-2481(08)70115-6.
[6] E. Oduah, R. Linhardt, and S. Sharfstein, “Heparin: Past, Present, and Future,” Pharmaceuticals, vol. 9, no. 3, p. 38, 2016, doi: 10.3390/ph9030038.
[7] D. Marson, E. Laurini, S. Aulic, M. Fermeglia, and S. Pricl, “Unchain My Blood: Lessons Learned from Self-Assembled Dendrimers as Nanoscale Heparin Binders,” Biomolecules, vol. 9, no. 8, p. 385, 2019, doi: 10.3390/biom9080385.
[8] R. J. Linhardt, “Heparin and anticoagulation,” Front. Biosci., vol. 21, no. 7, pp. 1372–1392, 2016, doi: 10.2741/4462.
[9] D. Mukherjee and E. J. Topol, “The role of low-molecular–weight heparin in cardiovascular diseases,” Prog. Cardiovasc. Dis., vol. 45, no. 2, pp. 139–156, 2002, doi: 10.1053/pcad.2002.127679.
[10] S. Aslani et al., “The applications of heparin in vascular tissue engineering,” Microvasc. Res., vol. 131, p. 104027, 2020, doi: 10.1016/j.mvr.2020.104027.
[11] P. Wang et al., “Heparin: An old drug for new clinical applications,” Carbohydr. Polym., vol. 295, p. 119818, 2022, doi: 10.1016/j.carbpol.2022.119818.
[12] C. Bal dit Sollier, J.-G. Dillinger, and L. Drouet, “Anticoagulant activity and pleiotropic effects of heparin,” J. Med. Vasc., vol. 45, no. 3, pp. 147–157, 2020, doi: 10.1016/j.jdmv.2020.03.002.
[13] P. Zhou, J.-X. Yin, H.-L. Tao, and H. Zhang, “Pathogenesis and management of heparin-induced thrombocytopenia and thrombosis,” Clin. Chim. Acta, vol. 504, pp. 73–80, 2020, doi: 10.1016/j.cca.2020.02.002.
[14] L. Litov et al., “Molecular Mechanism of the Anti-Inflammatory Action of Heparin,” Int. J. Mol. Sci., vol. 22, no. 19, p. 10730, 2021, doi: 10.3390/ijms221910730.
[15] A. Vitiello and F. Ferrara, “Low Molecular Weight Heparin, Anti-inflammatory/Immunoregulatory and Antiviral Effects, a Short Update,” Cardiovasc. Drugs Ther., vol. 37, no. 2, pp. 277–281, 2021, doi: 10.1007/s10557-021-07251-6.
[16] M.-T. Seffer, D. Cottam, L. G. Forni, and J. T. Kielstein, “Heparin 2.0: A New Approach to the Infection Crisis,” Blood Purif., vol. 50, no. 1, pp. 28–34, 2020, doi: 10.1159/000508647.
[17] L. Li, X. Tian, G. Feng, and B. Chen, “The predictive value of heparin-binding protein for bacterial infections in patients with severe polytrauma,” PLoS ONE, vol. 19, no. 12, p. e0300692, 2024, doi: 10.1371/journal.pone.0300692.
[18] J. Thachil, “The versatile heparin in COVID‐19,” J. Thromb. Haemost., vol. 18, no. 5, pp. 1020–1022, 2020, doi: 10.1111/jth.14821.
[19] L. Mazilu et al., “Thrombosis and Haemostasis challenges in COVID-19 – Therapeutic perspectives of heparin and tissue-type plasminogen activator and potential toxicological reactions—a mini review,” Food Chem. Toxicol., vol. 148, p. 111974, 2021, doi: 10.1016/j.fct.2021.111974.
[20] H. N. Magnani, “Rationale for the Role of Heparin and Related GAG Antithrombotics in COVID-19 Infection,” Clin. Appl. Thromb. Hemost., vol. 27, 2021, doi: 10.1177/1076029620977702.
[21] J. Hogwood, E. Gray, and B. Mulloy, “Heparin, Heparan Sulphate and Sepsis: Potential New Options for Treatment,” Pharmaceuticals, vol. 16, no. 2, p. 271, 2023, doi: 10.3390/ph16020271.
[22] S. Dey et al., “DNA origami,” Nat. Rev. Methods Primers, vol. 1, no. 1, 2021, doi: 10.1038/s43586-020-00009-8.
[23] S. Dastorani and R. Hasanzadeh Ghasemi, “Modeling and investigating the behavior of triangular origami DNA under the influence of laboratory temperature,” Sci. Technol. Mech. Eng., vol. 1, no. 1, pp. 58–69, 2023. doi: 10.22034/stme.2022.162701 (in Persian).
[24] S. Dastorani, R. H. Ghasemi, and R. Soheilifard, “A Study on the Bending Stiffness of a New DNA Origami Nano-Joint,” Mol. Biotechnol., vol. 63, no. 11, pp. 1057–1067, 2021, doi: 10.1007/s12033-021-00367-y.
[25] S. Dastorani et al., “Modelling and structural investigation of a new DNA Origami based flexible bio-nano joint,” Mol. Simul., vol. 46, no. 13, pp. 994–1003, 2020, doi: 10.1080/08927022.2020.1797019.
[26] S. Dastorani, M. Shariati, and R. Hasanzadeh Ghasemi, “Comparison of the bending behavior of DNA origami Nano beam using the nonlinear theory method and steered molecular dynamics simulation,” Nano World, vol. 19, no. 73, pp. 45–54, 2024 (in Persian)

[27] A. Monferrer et al., "DNA origami traps for large viruses," Cell Reports Physical Science, vol. 4, no. 1, p. 101237, 2023. [Online]. Available: https://doi.org/10.1016/j.xcrp.2022.101237

[28] A. Monferrer et al., "Broad-Spectrum Virus Trapping with Heparan Sulfate-Modified DNA Origami Shells," ACS Nano, vol. 16, no. 12, pp. 20002–20009, 2022. [Online]. Available: https://doi.org/10.1021/acsnano.1c11328

[29] D. Marson, E. Laurini, S. Aulic, M. Fermeglia, and S. Pricl, "Perceptions and Misconceptions in Molecular Recognition: Key Factors in Self-Assembling Multivalent (SAMul) Ligands/Polyanions Selectivity," Molecules, vol. 25, no. 4, p. 1003, 2020. [Online]. Available: https://doi.org/10.3390/molecules25041003

[30] L. E. Fechner et al., "Electrostatic binding of polyanions using self-assembled multivalent (SAMul) ligand displays – structure–activity effects on DNA/heparin binding," Chemical Science, vol. 7, no. 7, pp. 4653–4659, 2016. [Online]. Available: https://doi.org/10.1039/c5sc04801j

[31] G. Cavalieri et al., "Molecular Ballet: Investigating the Complex Interaction between Self-Assembling Dendrimers and Human Serum Albumin via Computational and Experimental Methods," Pharmaceutics, vol. 16, no. 4, p. 533, 2024. [Online]. Available: https://doi.org/10.3390/pharmaceutics16040533

[32] S. Chen, S. Huang, Y. Li, and C. Zhou, "Recent Advances in Epsilon-Poly-L-Lysine and L-Lysine-Based Dendrimer Synthesis, Modification, and Biomedical Applications," Frontiers in Chemistry, vol. 9, 2021. [Online]. Available: https://doi.org/10.3389/fchem.2021.659304

[33] D. Marson, E. Laurini, S. Aulic, M. Fermeglia, and S. Pricl, "Perceptions and Misconceptions in Molecular Recognition: Key Factors in Self-Assembling Multivalent (SAMul) Ligands/Polyanions Selectivity," Molecules, vol. 25, no. 4, p. 1003, 2020. [Online]. Available: https://doi.org/10.3390/molecules25041003.

[34] S. Nandi et al., "A robust ultra-microporous cationic aluminum-based metal-organic framework with a flexible tetra-carboxylate linker," Communications Chemistry, vol. 6, no. 1, 2023. [Online]. Available: https://doi.org/10.1038/s42004-023-00938-x

[35] D. Zhang et al., "Zirconium-Based Nanoscale Metal–Organic Framework with Metal-Bridged Cationic Linkers for the Selective Removal of Anionic Dyes," ACS Applied Nano Materials, vol. 7, no. 4, pp. 4349–4354, 2024. [Online]. Available: https://doi.org/10.1021/acsanm.3c05842

[36] M. Chawla, R. D. Kaushik, J. Singh, and Manila, "Optimization and computational studies evaluating molecular dynamics of EDA cored polymeric dendrimer," Scientific Reports, vol. 10, no. 1, 2020. [Online]. Available: https://doi.org/10.1038/s41598-020-77540-x

[37] D. Dey, S. Borkotoky, and M. Banerjee, "In silico identification of Tretinoin as a SARS-CoV-2 envelope (E) protein ion channel inhibitor," Computers in Biology and Medicine, vol. 127, p. 104063, 2020. [Online]. Available: https://doi.org/10.1016/j.compbiomed.2020.104063

[38] S. M. Douglas et al., "Rapid prototyping of 3D DNA-origami shapes with caDNAno," Nucleic Acids Research, vol. 37, no. 15, pp. 5001–5006, 2009. [Online]. Available: https://doi.org/10.1093/nar/gkp436

[39] E. Poppleton et al., "Design, optimization and analysis of large DNA and RNA nanostructures through interactive visualization, editing and molecular simulation," Nucleic Acids Research, vol. 48, no. 12, pp. e72–e72, 2020. [Online]. Available: https://doi.org/10.1093/nar/gkaa417

[40] A. Suma et al., "TacoxDNA: A user‐friendly web server for simulations of complex DNA structures, from single strands to origami," Journal of Computational Chemistry, vol. 40, no. 29, pp. 2586–2595, 2019. [Online]. Available: https://doi.org/10.1002/jcc.26029

[41] B. Mulloy, M. J. Forster, C. Jones, and D. B. Davies, "N.m.r. and molecular-modelling studies of the solution conformation of heparin," Biochemical Journal, vol. 293, no. 3, pp. 849–858, 1993. [Online]. Available: https://doi.org/10.1042/bj2930849

[42] K. Vanommeslaeghe et al., "CHARMM general force field: A force field for drug‐like molecules compatible with the CHARMM all‐atom additive biological force fields," Journal of Computational Chemistry, vol. 31, no. 4, pp. 671–690, 2009. [Online]. Available: https://doi.org/10.1002/jcc.21367

[43] A. Croitoru et al., "Additive CHARMM36 Force Field for Nonstandard Amino Acids," Journal of Chemical Theory and Computation, vol. 17, no. 6, pp. 3554–3570, 2021. [Online]. Available: https://doi.org/10.1021/acs.jctc.1c00254

[44] W. D. Cornell et al., "A Second Generation Force Field for the Simulation of Proteins, Nucleic Acids, and Organic Molecules," Journal of the American Chemical Society, vol. 117, no. 19, pp. 5179–5197, 1995. [Online]. Available: https://doi.org/10.1021/ja00124a002

[45] K. A. Thornalley, E. Laurini, S. Pricl, and D. K. Smith, "Enantiomeric and Diastereomeric Self‐Assembled Multivalent Nanostructures: Understanding the Effects of Chirality on Binding to Polyanionic Heparin and DNA," Angewandte Chemie International Edition, vol. 57, no. 28, pp. 8530–8534, 2018. [Online]. Available: https://doi.org/10.1002/anie.201802741